Inquiry into the misuse/abuse of benzodiazepines and other forms of pharmaceutical drugs in Victoria : final report / Drugs and Crime Prevention Committee.

  • Victoria. Parliament. Drugs and Crime Prevention Committee
Date:
2007
Catalogue details

Licence: In copyright

Credit: Inquiry into the misuse/abuse of benzodiazepines and other forms of pharmaceutical drugs in Victoria : final report / Drugs and Crime Prevention Committee. Source: Wellcome Collection.

    14/524
    2.3 Misuse and Abuse of Benzodiazepines and Other Pharmaceutical Drugs — Profiles of Use and Reasons for Use 91 Introduction 91 Profiles of use 91 Reasons for use 93 Patterns of use among recent Victorian injecting drug users 104 Conclusion 105 2.4 Accessing Benzodiazepines and Opioid Analgesics: ‘Doctor Shopping’, Diversion and Other Illegitimate Means of Acquisition 107 Introduction 107 ‘Doctor shopping’ 108 Forged, stolen or altered prescriptions 117 Acquisition from friends and family 120 The role of healthcare providers in diversion of pharmaceutical drugs 122 Theft of prescription drugs 127 Access by those engaging in criminal activity 129 Access via the Internet 130 Summary 132 Case example: The non-medical use of OxyContin® in the United States — Lessons for Australia? 132 Conclusion 136 PART B: Strategies to Reduce Misuse of Prescription Drugs 139 Section Three: Regulatory and Legal Issues 139 3.1 Legal and Regulatory Aspects of Pharmaceutical Drug Use 139 Commonwealth and state regulation of pharmaceutical drugs in Australia 140 The regulation and administration of pharmaceutical drugs and medicines in Victoria 160 3.2 Criminal and other Laws Pertaining to the Abuse of Prescription and other Pharmaceutical Drugs 163 General laws pertaining to criminal possession and trafficking 163 Victorian law 163 Conclusion 172 Section Four: Monitoring Systems for Prescription Drugs 173 4.1 Prescription Monitoring Systems in Northern America 173 Introduction 173 Regulation and monitoring of prescription drug abuse and diversion in the United States 174 Current approaches to prescription drug monitoring 177 Problems, controversies and concerns with PDMPs 190 The effectiveness of PDMPs in the United States 196 Prescription drug abuse, diversion and monitoring in British Columbia, Canada 199 Conclusion 209 4.2 Prescription Drug Monitoring in Australia — National Initiatives 211 Introduction 211 Medicare Australia 211 The Pharmaceutical Benefits Scheme 211 Medicare Australia and the ‘doctor shopping’ or ‘prescription shopping’ program 214 Conclusion 217
    digitised image 1
    digitised image 2
    digitised image 3